These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7262176)

  • 1. Disposition of azapropazone in chronic renal and hepatic failure.
    Breuing KH; Gilfrich HJ; Meinertz T; Wiegand UW; Jähnchen E
    Eur J Clin Pharmacol; 1981; 20(2):147-55. PubMed ID: 7262176
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of azapropazone in the elderly.
    Ritch AE; Perera WN; Jones CJ
    Br J Clin Pharmacol; 1982 Jul; 14(1):116-9. PubMed ID: 7104163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of azapropazone following single oral and intravenous doses.
    Breuing KH; Gilfrich HJ; Meinertz T; Jähnchen E
    Arzneimittelforschung; 1979; 29(6):971-2. PubMed ID: 582795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between azapropazone and warfarin.
    McElnay JC; D'Arcy PF
    Br Med J; 1977 Sep; 2(6089):773-4. PubMed ID: 912313
    [No Abstract]   [Full Text] [Related]  

  • 5. Concentration of azapropazone in synovial tissues and fluid.
    Spahn H; Thabe K; Mutschler E; Tillmann K; Gikalov I
    Eur J Clin Pharmacol; 1987; 32(3):303-7. PubMed ID: 3595703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein binding of azapropazone in patients with kidney and liver disease.
    Jähnchen E; Blanck KJ; Breuing KH; Gilfrich HJ; Meinertz T; Trenk D
    Br J Clin Pharmacol; 1981 Apr; 11(4):361-7. PubMed ID: 7259929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human pharmacokinetics of different i.v. doses of azapropazone (HPLC-determination) (author's transl)].
    Gikalov I; Kaufmann R; Schuster O
    Arzneimittelforschung; 1982; 32(4):423-6. PubMed ID: 7201814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacology and pharmacokinetics of azapropazone - a review.
    Jones CJ
    Curr Med Res Opin; 1976; 4(1):3-16. PubMed ID: 770078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of azapropazone and its principal 8-hydroxy-metabolite in plasma, urine and gastrointestinal mucosa determined by HPLC.
    Rainsford KD
    J Pharm Pharmacol; 1985 May; 37(5):341-5. PubMed ID: 2862244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofibrate disposition in renal failure and acute and chronic liver disease.
    Gugler R; Kürten JW; Jensen CJ; Klehr U; Hartlapp J
    Eur J Clin Pharmacol; 1979 Jun; 15(5):341-7. PubMed ID: 456406
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversible non-oliguric impairment of renal function during azapropazone treatment.
    Sipilä R; Skrifvars B; Törnroth T
    Scand J Rheumatol; 1986; 15(1):23-6. PubMed ID: 3961430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kinetics of digitoxin during antirheumatic therapy with azapropazone (author's transl)].
    Faust-Tinnefeldt G; Gilfrich HJ
    Arzneimittelforschung; 1977; 27(10):2009-11. PubMed ID: 579114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin.
    Urien S; Albengres E; Pinquier JL; Tillement JP
    Clin Pharmacol Ther; 1986 Jun; 39(6):683-9. PubMed ID: 3709033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The determination of azapropazone in blood plasma.
    Leach H
    Curr Med Res Opin; 1976; 4(1):35-43. PubMed ID: 1261300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azapropazone and renal function.
    Templeton JS
    Rheumatol Rehabil; 1978 Nov; 17(4):219-21. PubMed ID: 734316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of atracurium and its metabolites.
    Ward S; Weatherley BC
    Br J Anaesth; 1986; 58 Suppl 1():6S-10S. PubMed ID: 3754756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone aurothioglucose and azapropazone prednisolone].
    Faust-Tinnefeldt GF; Geissler HE
    Arzneimittelforschung; 1978; 28(2):337-41. PubMed ID: 346022
    [No Abstract]   [Full Text] [Related]  

  • 18. The uricosuric action of azapropazone: dose-response and comparison with probenecid.
    Higgens CS; Scott JT
    Br J Clin Pharmacol; 1984 Sep; 18(3):439-43. PubMed ID: 6487482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man.
    Thomson PD; Rowland M; Melmon KL
    Am Heart J; 1971 Sep; 82(3):417-21. PubMed ID: 5565429
    [No Abstract]   [Full Text] [Related]  

  • 20. Gemfibrozil absorption and elimination in kidney and liver disease.
    Knauf H; Kölle EU; Mutschler E
    Klin Wochenschr; 1990 Jul; 68(13):692-8. PubMed ID: 2381138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.